LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | BX-912 | 1.11 | uM | LJP5 | 3 | L21 | 72 | hr | 765 | 1612 | 3152 | 0.5114 | 0.4403 |
Hs 578T | BX-912 | 3.33 | uM | LJP5 | 1 | L20 | 72 | hr | 765 | 763 | 3140 | 0.2430 | -0.0013 |
Hs 578T | BX-912 | 3.33 | uM | LJP5 | 2 | L20 | 72 | hr | 765 | 952 | 3151 | 0.3021 | 0.1130 |
Hs 578T | BX-912 | 3.33 | uM | LJP5 | 3 | L20 | 72 | hr | 765 | 1032 | 3152 | 0.3274 | 0.1578 |
Hs 578T | BX-912 | 10 | uM | LJP5 | 1 | L19 | 72 | hr | 765 | 413 | 3140 | 0.1315 | -0.2611 |
Hs 578T | BX-912 | 10 | uM | LJP5 | 2 | L19 | 72 | hr | 765 | 439 | 3151 | 0.1393 | -0.2381 |
Hs 578T | BX-912 | 10 | uM | LJP5 | 3 | L19 | 72 | hr | 765 | 394 | 3152 | 0.1250 | -0.2774 |
Hs 578T | Selumetinib | 0.04 | uM | LJP6 | 1 | M12 | 72 | hr | 765 | 2112 | 3143 | 0.6718 | 0.6455 |
Hs 578T | Selumetinib | 0.04 | uM | LJP6 | 2 | M12 | 72 | hr | 765 | 2068 | 3095 | 0.6680 | 0.6374 |
Hs 578T | Selumetinib | 0.04 | uM | LJP6 | 3 | M12 | 72 | hr | 765 | 2035 | 3066 | 0.6637 | 0.6299 |
Hs 578T | Selumetinib | 0.12 | uM | LJP6 | 1 | M11 | 72 | hr | 765 | 1845 | 3143 | 0.5869 | 0.5400 |
Hs 578T | Selumetinib | 0.12 | uM | LJP6 | 2 | M11 | 72 | hr | 765 | 1633 | 3095 | 0.5275 | 0.4564 |
Hs 578T | Selumetinib | 0.12 | uM | LJP6 | 3 | M11 | 72 | hr | 765 | 1748 | 3066 | 0.5701 | 0.5107 |
Hs 578T | Selumetinib | 0.37 | uM | LJP6 | 1 | M10 | 72 | hr | 765 | 1641 | 3143 | 0.5220 | 0.4540 |
Hs 578T | Selumetinib | 0.37 | uM | LJP6 | 2 | M10 | 72 | hr | 765 | 1579 | 3095 | 0.5101 | 0.4324 |
Hs 578T | Selumetinib | 0.37 | uM | LJP6 | 3 | M10 | 72 | hr | 765 | 1584 | 3066 | 0.5166 | 0.4382 |
Hs 578T | Selumetinib | 1.11 | uM | LJP6 | 1 | M09 | 72 | hr | 765 | 1532 | 3143 | 0.4873 | 0.4058 |
Hs 578T | Selumetinib | 1.11 | uM | LJP6 | 2 | M09 | 72 | hr | 765 | 1461 | 3095 | 0.4720 | 0.3782 |
Hs 578T | Selumetinib | 1.11 | uM | LJP6 | 3 | M09 | 72 | hr | 765 | 1460 | 3066 | 0.4762 | 0.3808 |
Hs 578T | Selumetinib | 3.33 | uM | LJP6 | 1 | M08 | 72 | hr | 765 | 1409 | 3143 | 0.4482 | 0.3492 |
Hs 578T | Selumetinib | 3.33 | uM | LJP6 | 2 | M08 | 72 | hr | 765 | 1349 | 3095 | 0.4358 | 0.3248 |
Hs 578T | Selumetinib | 3.33 | uM | LJP6 | 3 | M08 | 72 | hr | 765 | 1325 | 3066 | 0.4322 | 0.3155 |
Hs 578T | Selumetinib | 10 | uM | LJP6 | 1 | M07 | 72 | hr | 765 | 1129 | 3143 | 0.3591 | 0.2103 |
Hs 578T | Selumetinib | 10 | uM | LJP6 | 2 | M07 | 72 | hr | 765 | 1114 | 3095 | 0.3599 | 0.2048 |
Hs 578T | Selumetinib | 10 | uM | LJP6 | 3 | M07 | 72 | hr | 765 | 1063 | 3066 | 0.3467 | 0.1785 |